NCT01010945 - Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 3, 2010

Primary Completion Date

January 25, 2012

Study Completion Date

January 25, 2012

Conditions

Advanced Pancreatic Cancer

Interventions

DRUG

erlotinib

administered orally

DRUG

gemcitabine

administered intravenously

DRUG

nab-paclitaxel

administered intravenously

Trial Locations (5)

Fox Chase Cancer Center, Philadelphia

University of North Carolina, Chapel Hill

Vanderbilt Ingram Cancer Center, Nashville

University of Colorado Cancer Center, Aurora

Desert Comprehensive Cancer Center, Palm Springs